由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
_pennystock版 - zz Biotech Calendar: More Key Clinical Trial Dates
相关主题
September's Biopharma Catalyst Calendar(zt from 168)【主贴】GTXI
INCY似乎庄家在吸筹 (转载)去年5月到现在通过和不通过FDA的生拉简要分析 (斑竹发包子)
[合集] Biotech Stocks Facing FDA Approval 四月至十月转帖一个PB曾经写关于三个减肥药的帖子
【技术贴-生拉小组】今日生拉帖子(6月25号)老牛哥,关于你养两个神龟《ARNA和VVUS》
UPDATE 1-US FDA panel rejects Jazz drug for fibromyalgia有人捞GTXI么?
fda dates/decisions(updated 6/9/2009)bpsg真是抗跌也抗涨啊
低价的FDA Decision Calendar (9月份,10月份,11月份,12月份5月26号pick讨论之-飞刀
【Biotech Event Thread】2009 OctGTXI是要飞了么?
相关话题的讨论汇总
话题: iii话题: clinical话题: drug话题: phase话题: company
1 (共1页)
p***o
发帖数: 714
1
Unlike U.S. Food and Drug Administration drug approvals, which are more
precisely timed, the release dates for data from clinical trials is bit
fuzzier, so the timelines here are culled from company guidance when
possible.
The working list of clinical trials expected to complete in 2009 is fairly
long, so expect more information on clinical trials to watch in the coming
weeks.
Company: GTx(GTXI)
Drug/indication: Acapodene for precancerous prostate lesions (high-grade PIN)
Clinical trial event: phase III top-line results
Timing: late summer
The phase III study will determine if treatment with Acapodene can reduce
the occurrence of prostate cancer in men with high-grade PIN -- precancerous
prostate lesions that place men at higher risk for prostate cancer.
Company: Incyte(INCY)
Drug/indication: INCB18424 for psoriasis
Clinical trial event: phase II results
Timing: late summer
Incyte recently announced agreement with the FDA on endpoints for a phase
III study of oral '8424 in patients with myelofibrosis. But the company is
also developing a topical form of the drug for the treatment of mild to
moderate psoriasis.
Company: Jazz Pharmaceuticals(JAZZ)
Drug/indication: JZP-6 for fibromyalgia
Clinical trial event: phase III top-line results
Timing: mid-2009
This is the second of two phase III studies of JZP-6 in patients with
fibromyalgia. Results from the first study were announced in last November
and then presented at a medical meeting last week. JZP-6 contains the same
active ingredient as in Xyrem, a drug marketed by Jazz for the treatment of
excessive daytime sleepiness.
Company: Orexigen Therapeutics(OREX)
Drug/indication: Contrave for obesity
Clinical trial event: Phase III top-line results
Timing: third quarter
Three phase III studies treating obese patients with Contrave or placebo for
one year will report results in the third quarter. Orexigen reported data
from a previous phase III study in January.
Company: Vivus(VVUS)
Drug/indication: Qnexa for obesity
Clinical trial event: phase III top-line results
Timing: third quarter
Two phase III studies treating obese patients with Qnexa or placebo for one
year will report results in the third quarter.
Company: Alkermes(ALKS)
Drug/indication: Vivitrol for opioid dependence
Clinical trial event: phase III top-line results
Timing: fourth quarter
Alkermes is seeking to expand the commercial market for Vivitrol beyond its
current use as a treatment for alcohol dependence.
Company: Celgene(CELG)
Drug/indication: Apremilast for psoriatic arthritis
Clinical trial event: phase II results
Timing: mid 2009
Apremilast is a drug designed to treat psoriasis and other inflammatory
diseases.
Company: Poniard Pharmaceuticals(PARD)
Drug/indication: Picoplatin for small cell lung cancer
Clinical trial event: phase III results
Timing: third quarter
Poniard is developing picoplatin in a variety of cancer indications, but the
data from the phase III study in small cell lung cancer, if positive, will
form the basis of the company's initial approval filing with the FDA.
Company: Medarex(MEDX)
Drug/indication: ipilimumab for metastatic melanoma
Clinical trial event: phase III top-line results
Timing: end of 2009
The phase III study enrolls patients with previously untreated metastatic
melanoma and treats them with a combination of ipilimumab plus the
chemotherapy dacarbazine or dacarbazine plus placebo.
1 (共1页)
相关主题
GTXI是要飞了么?UPDATE 1-US FDA panel rejects Jazz drug for fibromyalgia
VVUS再次Positive Resultsfda dates/decisions(updated 6/9/2009)
gtxi @2.9低价的FDA Decision Calendar (9月份,10月份,11月份,12月份
减肥药怎么玩【Biotech Event Thread】2009 Oct
September's Biopharma Catalyst Calendar(zt from 168)【主贴】GTXI
INCY似乎庄家在吸筹 (转载)去年5月到现在通过和不通过FDA的生拉简要分析 (斑竹发包子)
[合集] Biotech Stocks Facing FDA Approval 四月至十月转帖一个PB曾经写关于三个减肥药的帖子
【技术贴-生拉小组】今日生拉帖子(6月25号)老牛哥,关于你养两个神龟《ARNA和VVUS》
相关话题的讨论汇总
话题: iii话题: clinical话题: drug话题: phase话题: company